View Partner

• • 

    Austria Wirtschaftsservice GmbH (aws)

    • is the Austrian federal promotional bank. It assists companies in their implementation of innovative projects by granting loans, awarding subsidies and issuing guarantees at favorable interest rates, particularly in cases in which it is not possible for these companies to obtain the necessary funds in a sufficient amount from other sources of financing. In addition, it provides support in the form of specific information, advisory and other services to prospective, established and expanding companies. Syconium Lactic Acid GmbH is supported by aws. www.awsg.at
  • 

    University of Natural Resources and Life Sciences, Vienna, Austria (BOKU)

    • Syconium Lactic Acid GmbH is a spin off company of the Department of Biotechnology. www.boku.ac.at
  • 

    The Austrian Centre of Industrial Biotechnology (acib)

    • bundles the expertise of key researchers from seven Austrian universities in the multiple disciplines of industrial biotechnology and bioengineering, as well as attracting national and international biotechnological industry, and international renowned research institutions as integrated project partners. The centre wants to be the preferred partner for precompetitive research in industrial biotechnology, focused on biocatalysis, enzymes, metabolic engineering and (pharmaceutical) protein production. ACIB partners get access to innovative scientific concepts, condensed academic brain power, and the broad methodological expertise required in order to develop unique bioprocesses and products. ACIB’s ambitious research programme includes development of new microbial and mammalian expression systems and concepts, extended innovative applications of biocatalysis, and understanding bioproduction on a molecular and genome wide basis. Syconium Lactic Acid GmbH is a company partner within acib. www.acib.at
   

The Idea for Syconium Lactic Acid GmbH was developed between the scientific experts Diethard Mattanovich and Michael Sauer and the expert for business development in the biotech industry Otto Kanzler. With the involvement of the private investor Leopold Sandler (Managing Director of GLD Holding GmbH) and the entry of Michael Hammerschmid as general manager Syconium Lactic Acid GmbH was founded in July 2014.

• 

  Michael Hammerschmid

  • CEO
  • Studied Food- and Biotechnology at the University of Natural Resources and Life Sciences, Vienna, and has more than 17 years professional experience in the biopharmaceutical industry. He has held different leading positions, mainly at Boehringer Ingelheim RCV, Vienna (1994-2001, 2003-2013). In this period M. Hammerschmid developed strong knowledge and management skills in a constantly changing organization. He headed different functional units such as process science, production, as well as quality control and support units, managing international contract manufacturing projects and administrating QC samples. The experience of working as COO in a start up company in the field of medical diagnostic supplemented his experience for the specific needs for the initial stage of an organization (VBC-Genomics, 2002-2003). In addition, M. Hammerschmid is CEO and co-founder of Transform Science Management GmbH (www.transform-science.com)
• 

  Diethard Mattanovich

  • Co-founder of Syconium Lactic Acid GmbH
  • Full Professor of Microbial Cell Factory Design, BOKU University of Natural Resources and Life Sciences, Dept. of Biotechnology since 2012. His research interests are biotechnology of microorganisms, with a focus on production of recombinant proteins and metabolites with bacteria, yeasts and filamentous fungi, and systems biotechnology as the discipline unifying quantitative biology and bioprocess engineering. He published about 120 peer-reviewed papers, 7 book chapters, 40 invited lectures, 15 patents within the field. In addition D. Mattanovich is member of International Yeast Commission, Elected Academic Member of the Executive Board of the European Federation of Biotechnology (EFB) and Associate Editor of Microbial Cell Factories and Microbiology (UK).

• 

  Otto Kanzler

  • Co-founder of Syconium Lactic Acid GmbH
  • Has more than 30 years experience in process- and business development in the biotech industry. As of 2007 he is serving as Management Consultant for production and technology-development for biotech- and pharmaceutical industry, specified for strategic and economic issues. Between 1993 and 2007 he was head of biopharmaceutical coordination and planning at Boehringer Ingelheim Austria, Vienna, responsible for the economic issues of the industrial biopharmaceutical business. Prior to this he was head of process development for biopharmaceutical processes at Boehringer Ingelheim Austria (1981-1993). In addition, Otto Kanzler is CEO and co-founder of Evercyte GmbH (www.evercyte.com), CFO and co-founder of TAmiRNA GmbH (www.tamirna.com) and CEO and founder of Chorus GmbH (www.chorus.co.at), all are Austrian-based Biotech-Companies.
• 

  Michael Sauer

  • Co-founder of Syconium Lactic Acid GmbH
  • Studies of biotechnology at the Swiss Federal Institute of Technology in Zurich (ETHZ) - PhD in biochemistry at the University of Vienna - Postdoc at the University of Milano-Bicocca - trainee as patent assessor in Frankfurt am Main - head of research of the School of Bioengineering, FH Campus Wien - now senior scientist at the Department of Biotechnology, BOKU Wien and key researcher at ACIB GmbH - habilitation in industrial microbiology - head of the CD Laboratory for Biotechnology of Glycerol - research projects are dedicated to microbial conversion of biomass derived resources into chemicals, employing metabolic engineering and bioprocess engineering based on metabolic modeling approaches, published about 50 peer reviewed papers
• 

  GLD Holding GmbH

  • Co-founder of Syconium Lactic Acid GmbH
  • Kirchenweg 6, 3233 Kilb, Austria, FN 270904P
    
    www.gld-invest-group.com